DNA DAMAGE AND CELL KILLING BY CAMPTOTHECIN AND ITS DERIVATIVE IN HUMAN LEUKEMIA HL-60 CELLS

被引:72
作者
YOSHIDA, A
UEDA, T
WANO, Y
NAKAMURA, T
机构
[1] First Department of Internal Medicine, Fukui Medical School, Fukui, 910-11, Shimoaizuki, Matsuoka‐cho, Yoshida‐ gun
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1993年 / 84卷 / 05期
关键词
CAMPTOTHECIN; DNA DAMAGE; HL-60;
D O I
10.1111/j.1349-7006.1993.tb00177.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Camptothecin (CPT) has been recognized as a topoisomerase I (Topo I) inhibitor. However, the mechanism of cytotoxicity of this agent remains unknown. In the present study, we analyzed the kinetics of Topo I-mediated DNA single-strand breaks and internucleosomal DNA cleavage produced by CPT and its derivative, 7-ethyl-10-hydroxycamptothecin (SN-38), in HL-60 cells. DNA single-strand breaks were detected using alkaline sucrose gradient centrifugation when HL-60 cells were incubated with 10 muM CPT or 10 muM SN-38 for 30 min. These DNA single-strand breaks were rapidly repaired after drug removal, while the cytotoxic action of these drugs was sustained. Treatment of HL-60 cells with CPT or SN-38 for 3 h produced extensive degradation of DNA. Agarose gel electrophoresis showed a ladder of DNA fragments consisted of multimers of approximately 200 base pairs, characteristic of apoptosis. Interestingly, this type of DNA fragmentation was also induced within 4 h after repair of DNA single-strand breaks, and subsequently loss of cell viability was observed. When zinc ion, a potent inhibitor of endonuclease, was added to drug-free medium after treatment with CPT or SN-38, internucleosomal DNA cleavage was abolished. Furthermore, addition of zinc ion reduced the loss of cell viability. These data suggest that Topo I-mediated DNA single-strand breaks may be necessary but are not sufficient for cell death, and the endonuclease involved in induction of internucleosomal DNA cleavage may play an important role in HL-60 cell death induced by Topo I inhibitor.
引用
收藏
页码:566 / 573
页数:8
相关论文
共 32 条
[1]   CHARACTERIZATION OF A MAMMALIAN MUTANT WITH A CAMPTOTHECIN-RESISTANT DNA TOPOISOMERASE-I [J].
ANDOH, T ;
ISHII, K ;
SUZUKI, Y ;
IKEGAMI, Y ;
KUSUNOKI, Y ;
TAKEMOTO, Y ;
OKADA, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (16) :5565-5569
[2]   ACTIVATION OF PROGRAMMED CELL-DEATH (APOPTOSIS) BY CISPLATIN, OTHER ANTICANCER DRUGS, TOXINS AND HYPERTHERMIA [J].
BARRY, MA ;
BEHNKE, CA ;
EASTMAN, A .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (10) :2353-2362
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]  
COHEN JJ, 1984, J IMMUNOL, V132, P38
[5]   ENDOGENOUS ENDONUCLEASE-INDUCED DNA FRAGMENTATION - AN EARLY EVENT IN CELL-MEDIATED CYTOLYSIS [J].
DUKE, RC ;
CHERVENAK, R ;
COHEN, JJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (20) :6361-6365
[6]   ZN++ INHIBITS BOTH TUMOR NECROSIS FACTOR-MEDIATED DNA FRAGMENTATION AND CYTOLYSIS [J].
FLIEGER, D ;
RIETHMULLER, G ;
ZIEGLERHEITBROCK, HWL .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (02) :315-319
[7]  
GALLO RC, 1971, J NATL CANCER I, V46, P789
[8]   PURIFICATION OF DNA FROM FORMALDEHYDE FIXED AND PARAFFIN EMBEDDED HUMAN-TISSUE [J].
GOELZ, SE ;
HAMILTON, SR ;
VOGELSTEIN, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 130 (01) :118-126
[9]  
GOTTLIEB JA, 1970, CANCER CHEMOTH REP 1, V54, P461
[10]   DIFFERENTIAL EXPRESSION OF DNA TOPOISOMERASES-I AND TOPOISOMERASES-II DURING THE EUKARYOTIC CELL-CYCLE [J].
HECK, MMS ;
HITTELMAN, WN ;
EARNSHAW, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (04) :1086-1090